5751 - 5800 of 9145 Results
Title
Year
-
OPENTitle: Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodiesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 5End Page: 5Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-0879-zBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-020-0879-z.pdfCitation Count: 42
-
OPENTitle: Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene doseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 5Start Page: 2095End Page: 2116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12835Best OA location URL: https://escholarship.org/uc/item/8nk3j1qrCitation Count: 21
-
OPENTitle: mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double‐Blind, Placebo‐Controlled Futility Trial and 1‐Year Biomarker Longitudinal AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 778End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28923Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9018525Citation Count: 39
-
OPENTitle: Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s diseaseJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 28Issue #: 5Start Page: 1720End Page: 1732Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41418-020-00698-4Best OA location URL: https://www.nature.com/articles/s41418-020-00698-4.pdfCitation Count: 11
-
OPENTitle: Frequency and burden of gastrointestinal symptoms in familial dysautonomiaJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 31Issue #: 1Start Page: 109End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00735-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7906911Citation Count: 8
-
OPENTitle: Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational TractographyJournal Name: Journal of Nuclear MedicinePublisher: Society of Nuclear MedicineVol: 62Issue #: 4Start Page: 545End Page: 552Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2967/jnumed.120.248500Best OA location URL: https://jnm.snmjournals.org/content/jnumed/62/4/545.full.pdfCitation Count: 32
-
OPENTitle: Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trialsJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 3Start Page: 215End Page: 221Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00681-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7341538Citation Count: 16
- Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures2019OPENTitle: Prediction of cognitive progression in Parkinson's disease using three cognitive screening measuresJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.08.006Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.08.006Citation Count: 43
-
OPENTitle: Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease PenetranceJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 10Start Page: 1755End Page: 1764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28189Citation Count: 87
- Renal Dysfunction Might Be a Marker of Cardiovascular Dysautonomia in Prodromal Α‐Synucleinopathies2020OPENTitle: Renal Dysfunction Might Be a Marker of Cardiovascular Dysautonomia in Prodromal Α‐SynucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 2Start Page: 374End Page: 374Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27840Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7122792Citation Count: 2
-
OPENTitle: Resting‐State Functional Connectivity Predicts STN DBS Clinical ResponseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 662End Page: 671Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28376Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7987812Citation Count: 42
- Genetic analysis of neurodegenerative diseases in a pathology cohort2018RESTRICTEDTitle: Genetic analysis of neurodegenerative diseases in a pathology cohortJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 214.e1End Page: 214.e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.11.007Citation Count: 52
-
OPENTitle: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemicJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049755Best OA location URL: https://doi.org/10.1242/dmm.049755Citation Count: 0
-
OPENTitle: 4319 Team Science in Parkinson’s Research: Connecting Clinicians and Computational TeamsJournal Name: Journal of Clinical and Translational SciencePublisher: Cambridge University Press (CUP)Vol: 4Issue #: s1Start Page: 118End Page: 119Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/cts.2020.359Citation Count: 0
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities2021RESTRICTEDTitle: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunitiesJournal Name: Physiology NewsPublisher: The Physiological SocietyVol:Issue #: Autumn 123Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.36866/123.32Citation Count: 0
- Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)2019RESTRICTEDTitle: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008Citation Count: 0
-
OPENTitle: 0908 Multi-modal Recruitment of Individuals with REM Sleep Behavior Disorder into a Longitudinal Prodromal Parkinson’s StudyJournal Name: SLEEPPublisher: Oxford University Press (OUP)Vol: 46Issue #: Supplement_1Start Page: A400End Page: A400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsad077.0908Best OA location URL: https://academic.oup.com/sleep/article-pdf/46/Supplement_1/A400/50468111/zsad077.0908.pdfCitation Count: 0
- Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)2017RESTRICTEDTitle: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002Citation Count: 0
- A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)2018RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
- Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)2019RESTRICTEDTitle: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050Citation Count: 0
-
OPENTitle: 6 Association Between American Football Play and Parkinson's Disease: Analysis of the Fox Insight Data SetJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 29Issue #: s1Start Page: 415End Page: 416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617723005507Citation Count: 0
- Carepartner Communication on Parkinson Disease Psychosis (4116)2020RESTRICTEDTitle: Carepartner Communication on Parkinson Disease Psychosis (4116)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116Citation Count: 0
- Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)2017RESTRICTEDTitle: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013Citation Count: 0
- Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)2019RESTRICTEDTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006Citation Count: 0
- Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)2020RESTRICTEDTitle: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402Citation Count: 0
-
OPENTitle: Biological Staging of the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the Research Neuronal α-synuclein Disease Integrated Staging System (NSD-ISS) (P11-3.009)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 102Issue #: 7_supplement_1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000204771Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/154631Citation Count: 0
- If You Don’t Ask, You Won’t Know: Inclusive Recruitment Strategies for the Parkinson Progression Markers Initiative (PPMI)2024RESTRICTEDTitle: If You Don’t Ask, You Won’t Know: Inclusive Recruitment Strategies for the Parkinson Progression Markers Initiative (PPMI)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 122Issue #:Start Page: 106689End Page: 106689Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106689Citation Count: 0
-
OPENTitle: Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational StudyJournal Name: JMIR Research ProtocolsPublisher: JMIR Publications Inc.Vol: 14Issue #:Start Page: e71955End Page: e71955Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/71955Best OA location URL: https://doi.org/10.2196/71955Citation Count: 0
- Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial results2025RESTRICTEDTitle: Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial resultsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 134Issue #:Start Page: 107560End Page: 107560Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107560Citation Count: 0
- Carrying on a Father's Legacy2025RESTRICTEDTitle: Carrying on a Father's LegacyJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 4Start Page: 40End Page: 40Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0001125860.72537.e7Citation Count: 0
- Exploring MAPT-containing H1 and H2 haplotypes in Parkinson’s disease across diverse populations2026OPENTitle: Exploring MAPT-containing H1 and H2 haplotypes in Parkinson’s disease across diverse populationsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01394-9Best OA location URL: https://www.nature.com/articles/s41531-026-01394-9_reference.pdfCitation Count: 0
-
OPENTitle: Protein Profiling of RGS6, a Pleiotropic Gene Implicated in Numerous Neuropsychiatric Disorders, Reveals Multi-Isoformic Expression and a Novel Brain-Specific IsoformJournal Name: eneuroPublisher: Society for NeuroscienceVol: 9Issue #: 1Start Page: ENEURO.0379End Page: 21.2021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0379-21.2021Best OA location URL: https://doi.org/10.1523/eneuro.0379-21.2021Citation Count: 13
-
OPENTitle: Crystal structure of the WD40 domain dimer of LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 116Issue #: 5Start Page: 1579End Page: 1584Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.1817889116Best OA location URL: https://www.pnas.org/content/pnas/116/5/1579.full.pdfCitation Count: 100
-
OPENTitle: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 7Start Page: 768End Page: 773Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2018-320151Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/7/768.full.pdfCitation Count: 62
-
OPENTitle: Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 28Issue #:Start Page: 102391End Page: 102391Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2020.102391Best OA location URL: https://doi.org/10.1016/j.nicl.2020.102391Citation Count: 40
- Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?2019RESTRICTEDTitle: Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?Journal Name: Molecular Genetics and MetabolismPublisher: Elsevier BVVol: 128Issue #: 4Start Page: 470End Page: 475Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ymgme.2019.10.001Citation Count: 41
-
OPENTitle: Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine ChallengeJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 93Issue #: 12Start Page: 1089End Page: 1098Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2022.10.012Citation Count: 86
-
OPENTitle: Inflammatory profile in LRRK2-associated prodromal and clinical PDJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 122End Page: 122Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0588-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0588-5Citation Count: 79
-
OPENTitle: Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric formJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 106Issue #:Start Page: 191End Page: 204Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.07.007Best OA location URL: https://doaj.org/article/416c1a4af85442e1a86a6af150c46583Citation Count: 40
- The KV7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian rats2013RESTRICTEDTitle: The KV7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian ratsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 545Issue #:Start Page: 59End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.04.017Citation Count: 7
-
OPENTitle: A novel class of negative allosteric modulators of NMDA receptor functionJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 25Issue #: 23Start Page: 5583End Page: 5588Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2015.10.046Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7971076Citation Count: 19
- Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics2020OPENTitle: Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane DynamicsJournal Name: MoleculesPublisher: MDPI AGVol: 25Issue #: 11Start Page: 2561End Page: 2561Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules25112561Best OA location URL: https://www.mdpi.com/1420-3049/25/11/2561/pdf?version=1591348343Citation Count: 4
- The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson’s disease2020RESTRICTEDTitle: The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 9Start Page: 1275End Page: 1283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-020-02224-9Citation Count: 2
- Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum2022RESTRICTEDTitle: Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellumJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 178Issue #: 9Start Page: 924End Page: 931Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2022.05.002Citation Count: 6
-
OPENTitle: Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 22End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.016Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9310432Citation Count: 10
-
OPENTitle: Improved diagnosis of Parkinson's disease from a detailed olfactory phenotypeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 10Start Page: 714End Page: 721Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.447Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.447Citation Count: 15
- Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors2019RESTRICTEDTitle: Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptorsJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 174Issue #:Start Page: 113788End Page: 113788Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2019.113788Citation Count: 7
-
OPENTitle: Patient-centred management of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 887End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30359-8Best OA location URL: http://www.thelancet.com/article/S1474442220303598/pdfCitation Count: 2
-
OPENTitle: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stressJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: 10Start Page: 11223End Page: 11234Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1096/fj.201900830rBest OA location URL: https://doi.org/10.1096/fj.201900830rCitation Count: 129
- Increased substantia nigra echogenicity in LRRK2 family members without mutations2018RESTRICTEDTitle: Increased substantia nigra echogenicity in LRRK2 family members without mutationsJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 9Start Page: 1504End Page: 1505Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27443Citation Count: 2